Viyash Scientific Ltd - Formulations drive robust growth | Q1FY27 Company Update
Viyash’s Q1FY27 was a beat to our estimates, driven by surge in formulation business, especially in Europe, India and Emerging markets. API witnessed a slowdown in growth to 3% yoy. However, the Q1FY27 results proved the sustenance of high margins for the merged entity, driven by synergies, improved profitability in emerging markets and scale up of complex API. Going ahead, the growth will be an all-round performance due to improvement in API sales expected 2QFY27E onwards. Viyash aims to increase R&D spending & sales network for the companion animal portfolio, increase capacities in emerging markets and capitalize on genericization of animal health. Viyash also aims to capitalize on the vast CDMO opportunities with an aim to likely double its business in three years. All these factors together converge into a robust 17%/ 20%/ 41% CAGR in Revenue/ EBITDA/ PAT over FY26-FY28E. We value Viyash at 15x Jun’28E EV/EBITDA (unchanged) to arrive at a TP of Rs 345/sh (previously Rs 330/sh) and maintain BUY rating due to attractive valuations.
Viyash Scientific ltd. Stock Price Chart
Beat on revenue growth led by formulations:
Viyash reported a strong 19.5% yoy growth in consol. revenues at Rs 9.5bn (beat to our estimates), driven by surge in the formulation business (+33% yoy), especially in the Europe, India and Emerging markets. API witnessed a slowdown in growth to 3% yoy.
Sustains guided margins led by merger benefits:
Viyash reported a 540bps jump in EBITDA margins at 21.6% (excludes ESOP cost), outperforming its guidance largely due to synergies of the merger, shift to complex API and Intermediates from commodity products and improved profitability in emerging markets. EBITDA surged by 59% yoy to Rs 2.1bn. Consol. Adj. PAT doubled to Rs 908mn on a low base.
More synergies to unlock; focus shift on focused growth:
The company continues to phase out low-margin products while prioritizing higher-value new launches. Further, R&D pipeline remains robust, with 19+ products in development, reinforcing future growth visibility. Viyash has now proven the sustainability of margins and are likely to ramp up synergies (R&D, procurement, cross selling) to the tune of Rs 1.3bn annually. A very high pedigree of experienced and focused management team further drives our conviction on the evolution of this business. Going ahead, Viyash aims to increase R&D spending & sales network (Europe) for the companion animal portfolio, increase capacities in emerging markets, leverage the existing sales network of Bio for Life in Italy, shift towards complex API & Intermediates from commodity products and capitalize on genericization of animal health. Several customers delayed their purchase in the API segment due to high cost, which has now picked up momentum. Viyash also aims to double its CDMO business in three years by leveraging its rich client base of innovators. All these factors together converge into a robust 17%/ 20%/ 41% CAGR in Revenue/ EBITDA/ PAT over FY26-FY28E. Remain positive on Viyash.
Valuation, view and key risks:
We value Viyash at 15x Jun’28E EV/EBITDA to arrive at a TP of Rs 345/sh (Rs 330/sh previously). We maintain BUY rating due to attractive valuation. The upward revision in TP is due to valuation roll forward. Key Risks: Geographic and product-related challenges, delays in synergy realization, and high competition in CDMO.
Company website: https://viyash.com/
| Rating | BUY |
|---|---|
| CMP* | INR 263 |
| Target Price | INR 345 |
| Upside | 31% |
*CMP is as per report published date
Click to download the full Viyash Scientific Ltd. Q1FY27 Company Update
Analyst:
- Sahil Sanghvi - Research Analyst, Institutional Equities (NISM-201900004744)
- Uvais Khatri - Research Associate, Institutional Equities (NISM-202300049054)
FAQs on Viyash Scientific Ltd. Q1FY27 Company Update
What is the target price for Viyash Scientific?
The supplied research sets a target price of ₹345 per share, compared with the reported CMP of ₹263. This is a research-based valuation estimate and is not a guaranteed return.
What is the rating on Viyash Scientific?
The supplied research maintains a BUY rating on Viyash Scientific, citing attractive valuations, formulation-led growth, margin sustainability and potential synergies.
How did Viyash Scientific perform in Q1FY27?
Consolidated revenue increased 19.5% year-on-year to ₹9.5 billion. EBITDA rose 59% to ₹2.1 billion, while consolidated adjusted PAT doubled to ₹908 million.
What drove Viyash Scientific's Q1FY27 growth?
Growth was led by the formulation business, which increased 33% year-on-year, particularly across Europe, India and emerging markets. API growth moderated to 3% year-on-year.
What supported Viyash Scientific's margin expansion?
EBITDA margin increased 540 basis points year-on-year to 21.6%, supported by merger synergies, a shift toward complex APIs and intermediates, and improved profitability in emerging markets.
What are the key growth opportunities for Viyash Scientific?
Key opportunities include formulation growth, complex API and intermediate products, companion-animal healthcare, emerging-market capacity expansion and CDMO opportunities. The company also has more than 19 products in development.
What is Viyash Scientific's CDMO growth strategy?
Viyash Scientific aims to leverage its client base of innovators and expand its CDMO business, with the supplied research noting the company's aim to potentially double this business over three years.
What are the key risks for Viyash Scientific?
The supplied research identifies geographic and product-related challenges, delays in realizing synergies and high competition in the CDMO business as key risks.
Should investors buy Viyash Scientific shares?
The supplied research maintains a BUY rating. This represents the research firm's view and should not be considered personalised investment advice or a guarantee of future performance. Investors should conduct independent due diligence and consult a SEBI-registered investment adviser where appropriate.
Before You Trade, Strengthen Your Foundations with These Guides
- For a stronger understanding of indicators such as RSI, VWAP, and trendlines, check our 👉 Technical Analysis Fundamentals section.
- Want to refine your risk-reward planning? Explore our insights on 👉 Position Sizing & Risk Management Strategies.
- Checkout Viyash Scientific Ltd stock price chart and research report for analysis.
Disclaimer: - Investments in securities market are subject to market risk, read all the related document carefully before investing. https://www.mnclgroup.com/research-disclaimer
Latest Companies Updates
Archives
- February 2024
- October 2024
- November 2024
- December 2024
- February 2025
- March 2025
- April 2025
- May 2025
- June 2025
- July 2025
- August 2025
- September 2025
- October 2025
- November 2025
- December 2025
- January 2026
- March 2026
- February 2026
- April 2026
- May 2026
- June 2026
- July 2026
- August 2026
- September 2026
- October 2026
Related Blog
FIEM Industries - Riding the tailwinds of 2W boom | Q1FY27 Company Update
Jubilant Agri & Consumer Products Ltd. - Strong Quarter; Sticking to Continued Growth Trajectory | Q1FY27 Company Update
Landmark Cars - Growth intact; After-sales ramp-up to drive the next leg | Q1FY27 Company Update
TD Power Systems Ltd - Powering ahead on AI and export momentum | Q1FY27 Company update
Ecos Mobility Ltd - Strong business growth; but margin pressure persists | Q1FY27 Company Update
ESAB India Ltd - Healthy growth, sharper margins | Q1FY27 Company Update
Borosil Ltd - From capacity build-out to earnings growth | Q1FY27 Company Update
KSB Ltd - Transient Pause in Growth, Recovery Ahead | Q1FY27 Company update
Minda Corporation - Solid execution | Q1FY27 Company Update
Scoda Tubes - Muted Performance | Q1FY27 Company Update
IFGL Refractories - Domestic muted; overseas subsidiaries shine | Q1FY27 Company Upda
Triveni Turbine Ltd - Margins stumble; exports accelerate; H2 recovery remains | Q1FY27 Company update
Carysil Ltd - Scaling up growth; Earnings outlook strengthens | Q1FY27 Company Update
Venus Pipes & Tubes - In-line performance | Q1FY27 Company Update
Godawari Power & Ispat - Project Delays | Q1FY27 Company Update
Goldiam International Ltd - Strong B2B Execution; ORIGEM expansion turns calibrated | Q1FY27 Company Update
Travel Food Services Ltd - A long runway for growth | Q1FY27 Company Update
Entero Healthcare Ltd - Organic growth takes centre stage; margin expansion accelerates | Q1FY27 Company Update
Cello World - Steel & Glassware ramp-up key to revival | Q1FY27 Company Update
JNK India Ltd - Diversification provides improved growth visibility | Q1FY27 Company Update
Saksoft Ltd - Broadly in-line; maintain buy | Q1FY27 Company Update
SJS Enterprises Ltd - In-line Performance | Q1FY27 Company Update
RHI Magnesita India - Excellent Performance | Q1FY27 Company Update
Viyash Scientific Ltd - Formulations drive robust growth | Q1FY27 Company Update
Vesuvius India Ltd - Another weak quarter | 2QCY26 Company Update
La Opala RG - Cautiously optimistic | Q1FY27 Company Update
Ratnamani Metals & Tubes Ltd - Weak Quarter | Q1FY27 Company Update
Mrs Bectors Food - Strong quarter; Baking Multi-Year Growth | Q1FY26 Company Update
Kirloskar Ferrous Industries Ltd. - Navigating challenging times | Q1FY27 Company Update
The Anup Engineering Ltd. - Not Out of the Woods Yet | Q1FY27 Company Update
Mayur Uniquoters - Export Momentum Accelerates | Q1FY27 Company Update
Sundram Fasteners Ltd - Export recovery surprises positively | Q1FY27 Company Update
R Systems - Stable Quarter | Q2CY26 Company Update
Rashi Peripherals - Another record quarter | Q1FY27 Company Update
ASK Automotive Ltd. - New business addition drives re-rating | Q1FY26 Company Update
Wonderla Holidays - Chennai Strengthens Medium-Term Visibility | Q1FY27 Company Update
Happy Forgings Ltd - On a high growth trajectory; fairly priced | Q1FY27 Company Update
Inox India Ltd - Looking beyond a soft quarter; growth acceleration ahead | Q1FY27 Company update
Ethos Ltd. - Expanding reach, elevating the mix | Q1FY27 Company Update
Sri Lotus Developers and Realty - Robust Presales; Luxury redevelopment Momentum Gathers Pace | Q1FY27 Company Update
Pricol Ltd - Large business additions drive re-rating | Q1FY27 Company update
Aditya Vision Ltd - Scaling beyond core markets | Q1FY27 Company Update
Indegene Ltd - Broadly in-line; maintain buy | Q1FY27 Company Update
Redington Ltd - All-round beat | Q1FY27 Company update
Netweb Technologies India Ltd - AI systems drive growth; margins beat estimate | Q1FY27 Company update
Ivalue Infosolutions - Stable set in a seasonally weak quarter | Q1FY27 Company Update
Aurionpro solutions Ltd - Another subdued quarter | Q1FY27 Company Update
INOX India Ltd - FY26 Annual Report Analysis - Record FY26, Acceleration Ahead
Kirloskar Pneumatic - Slow start to the new fiscal | Company Update
TD Power Systems Ltd - FY26 Annual Report Analysis - Positive Readthrough | Company Update
Jubilant Agri & Consumer Products ltd. -Scaling Up for the Next Growth Cycle - Company Update
The Anup Engineering - Middle East Crisis Clouds Near-Term Outlook - Company Update
IFGL Refractories Ltd. - Domestic muted; overseas subsidiaries shine - Company Update
FIEM Industries Ltd. - Strong Execution and Margin Resilience - Company Update
La Opala RG - Near term pain, recovery building - Company Update
RHI Magnesita India Ltd. - Tough quarter; Price hikes to the rescue - Company Update
Ecos Mobility Ltd - Well-positioned to drive India's corporate mobility growth - Company Update
Mrs Bectors Food - Short-term headwinds; long term growth intact- Company Update
Cello World - Capacity ramp-up key to recovery - Company Update
Scoda Tubes Ltd. - Poor performance; Chasing strong recovery - Company Update
Goldiam International - B2B Cash cow, ORIGEM the next growth engine - Company Update
Landmark Cars - Consolidation to drive profitable growth - Company Update
Travel Food Services Ltd - Premiumization-led growth - Company Update
Saksoft Ltd - Weakness across top clients drags earnings - Company Update
Entero Healthcare Ltd - Consolidation Engine Gains Momentum - Company Update
Viyash Scientific Ltd. - Sustains high margins, focus on new growth avenues - Company Update
JNK India Ltd. - Growth visibility strengthens - Company Update
Godawari Power & Ispat Ltd. - Excellent performance - Company Update
Carysil Ltd - Expanding capacity, deepening global partnerships - Company Update
Ratnamani Metals and Tubes Ltd. - Recovery in sight - Company Update
Triveni Turbine Ltd. - Growth in Exports and Aftermarket keeps Outlook Healthy - Company update
TD Power Systems - Robust quarter; Large Generator Bet Strengthens Outlook | Company update
Rashi Peripherals Ltd - Stellar all-round performance | Company Update
Sri Lotus Developers and Realty Ltd - Robust presales; luxury demand driving outperformance - Company update
Kirloskar Ferrous Industries - Pricing power yet to fully reflect in spreads | Company Update
Vesuvius India Ltd. - Weak quarter; Analyst Meet KTA - Company Update
R Systems International Ltd - Margins shine; growth to rebound - Company update
SJS Enterprises Ltd - Premiumisation and Export-led Outperformance - Company Update
KSB Ltd. - Q1CY26 PAT trails sales; margins bite - Company Update
Sri Lotus Developers and Realty Ltd. ─ Strong Outlook, Relentless Focus on Growth | Q4FY26 Company Update
Vesuvius India Ltd. - Subdued quarter | Company update
Kirloskar Ferrous Industries - Shutdown and pricing weakness spoil the show | Company Update
Goldiam International - From export strength to domestic scale - Company Update
Ratnamani Metals and Tubes Ltd.: Core pipes weak; subsidiaries anchor margins - Company Update
Carysil Ltd: Crafting the future of modern kitchens - Company Update
Wonderla Holidays: Chennai Takes The Baton As Mature Parks Plateau - Company Update
Rashi Peripherals Ltd: Stellar quarter - Company Update
Triveni Turbine: Worst likely behind, recovery pending - Company update
The Anup Engineering: Through the Trough, Recovery in the offing - Company Update
Saksoft Ltd: Temporary headwinds, normalization in sight - Company Update
Mayur Uniquoters: Riding export momentum - Company Update
Scoda Tubes Ltd.: Slight miss; structural thesis intact - Company Update
TD Power Systems: Global demand fuelling growth visibility - Company Update
SJS Enterprises Ltd - Premiumisation and Export-led Outperformance - Company Update
Sundram Fasteners Ltd.: Exports spoil the show - Company Update
ASK Automotive Ltd. - Firing on all cylinders - Company Update
Kirloskar Ferrous Ind. - Casting and tubes outperform, spreads spoil the show | Company Update
IFGL Refractories Ltd. - Domestic focus continues to payoff; overseas improving gradually | Company Update
Borosil Ltd. - Glassware ignites growth; levers to power margins | Company Update
Venus Pipes & Tubes Ltd. - Export and welded drives confidence | Company Update
ESAB India - Encouraging quarter; growth in focus | Company Update
The Anup Engineering - All eyes on cash conversion | Company Update
Rashi Peripherals Ltd – Turns cashflow positive
Wonderla Holidays - Chennai on Track; Expansion Visibility Low | MNCL Research Update
R Systems International - Strong growth tempered by higher SG&A & RSU costs | MNCL Research Update
SJS Enterprises Ltd - Designed to outperform | MNCL Research Update
Channel checks - Opalware and Glassware - Borosil Sets the Benchmark in Opalware Retail
Goldiam International - LGD Momentum builds; ORIGEM scaling | Company Update
ASK Automotive Ltd – Meets Expectations; ALPS & Aftermarket to Drive Growth | MNCL Research Company Update
Sundram Fasteners Ltd. - Steady Domestic Momentum Offsets Export Weakness; upgrade to Accumulate - Company Update
JNK India Ltd – End of Overhang, Execution to Drive Growth | Q2FY26



